臨床泌尿器科74巻8号

2020年07月発行

特集 これが最新版！　過活動膀胱のトリセツ〈特別付録Web動画〉

〈過活動膀胱に対する新しい治療と未来展望〉

仙骨神経刺激療法（SNM）

著者： 林篤正¹ 沢田勇吾¹ 野村昌良¹

所属機関： ¹亀田メディカルセンターウロギネ科

ページ範囲：P.591 - P.599

文献概要

▶ポイント

・仙骨神経刺激療法（SNM）は主に求心路に作用し，正常な排尿サイクルへ戻す排尿の調整役として機能していると考えられている．

・リード線挿入術は治療の成否を決める重要な行程である．また，機器挿入術であるので感染対策が重要である．

・ボツリヌス毒素療法との比較試験では，SNMのほうが術後の合併症頻度が少ないと報告されている．

＊本論文中、［▶動画］マークのあるものにつきましては、関連する動画を見ることができます（公開期間：2022年7月末まで公開）。

参考文献

1） Zhang F, et al : Neural Pathways in Sacral Neuromadulation of Reflex Bladder Activety in Cats. Am J Physiol Renal Physiol 304 : F710-F717, 2013

2） Riazimand S-H, et al : Interaction Between Neuroteansmitter Antagonists and Effects of Sacral Neuromodulation in Rats With Chronically Hyperactive Bladder. BUJ Int 96 : 900-908, 2005

3） Li X, et al : Involvement of Opioid Receptors in Inhibition of Bladder Overactivity Induced by Sacral Neuromadulation in Pigs : A Possible Action Mechanism. Neurourol Urodyn 36 : 1742-1748, 2017

4） Wenzler DL, et al : Proof of Concept Trial on Changes in Current Perception Threshold After Sacral Neuromodulation. Neuoromodulation 18 : 228-231, 2015

5） Gill BC, et al : Real-Time Changes in Brain Activity During Sacral Neuromadulation for Overactive Bladder. J Urol 198 : 1379-1385, 2017

6） Kessler TM, et al : Sacral Neuromodulation for Urinary Retention. Nat Clin Pract Urol 5 : 657-666, 2008

7） Kavia R, et al : A Functional Magnetic Resonance Imaging Study of the Effect of Sacral Neuromodulation on Brain Responses in Women With Fowler's Syndrome. BUJ Int 105 : 366-372, 2010

8） Fowler CJ, et al : Studies of the Latency of Pelvic Floor Contraction During Peripheral Nerve Evaluation Show That the Muscle Response Is Reflexly Mediated. J Urol 163 : 881-883, 2000

9） Wyndaelle JJ, et al : Influence of Sacral Neuromodulation on Electrosensation of the Lower Urinary Tract. J Urol 163 : 221-224, 2000

10） Groen J, et al : Sacral Neuromodulation in Women With Idiopathic Detrusor Overactivity Incontinence : Decreased Overactivity but Unchanged Bladder Contraction Strength and Urethral Resistance During Voiding. J Urol 175 : 1005-1009, 2006

11） Amundsen CL, et al : Sacral Neuromodulation for Intractable Urge Incontinence : Are There Factors Associated With Cure? Urology 66 : 746-750, 2005

12） Richter HE, et al : Characteristics Associated With Treatment Response and Satisfyion in Woman Undergoing OnabotulinumtoxinA and Sacral Neuromadulation for Refractory Urgency Urinary Continence. J Urol 198 : 890-896, 2017

13） Nobrega RP, et al : Predicting a Successful Outcome in Sacral Neuromodulation Testing : Are Urodynamic Parameters Prognostic? Neurourol Urodyn 37 : 1007-1010, 2018

14） Noblett K, et al : Detailed Analysis of Adverse Events and Surgical Intervention in a Large Prospective Trial of Sacral Neuromodulation Therapy for Overactive Bladder Patients. Neurourol Urodyn 36 : 1136-1139, 2017

15） 山名哲郎, 他 : 便失禁に対する仙骨神経刺激療法 前向き多施設共同研究. 日本大腸肛門病会誌67 : 371-379, 2014

16） Jairam R, et al : Onset of Action of Sacral Neuromadulation in Lower Urinary Tract Dysfunction--What Is the Optimal Duration of Test Stimulation? J Urol 199 : 1584-1590, 2018

17） Tutolo M, et al : Efficacy and Safety of Sacral and Percutaneous Tibial Neuromodulation in Non-neurogenic Lower Urinary Tract Dysfunction and Chronic Pelvic Pain : A Systematic Review of the Literature. Eur Urol 73 : 406-418, 2018

18） Siegel S, et al : Results of prospective, randomized, multicenter study evaluating sacral neuromodulation with Interstim therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn 34 : 224-230, 2015

19） Noblett K, Siegel S, Mangel J, et al : Results of a Prospective, Multicenter Study Evaluating Quality of Life, and Efficacy of Sacral Neuromodulation at Twelve Months in Subjects With Symptoms of Overactive Bladder. Neurourol Urodyn 35 : 246-251, 2016

20） Siegel S, et al : Five-year Follow Up Results of a Prospective, Multicenter Study of Patients With Overactive Bladder Treated With Sacral Neuromadulation. J Urol 199 : 229-236, 2018

21） Moskowitz D, et al : Use of Third Line Therapy for Overactive Bladder in a Practice With Multiple Subspecialty Providers--Are We Doing Enough? J Urol 199 : 779-784, 2018

22） Amundsen CL, et al : Two-Year Outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence : A Randomized Trial. Euro Urol 74 : 66-73, 2018

23） Harvie HS, et al : Cost-Effectiveness of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence : Results of the ROSETTA Randomized Trial. J Urol 203 : 969-977, 2020

24） Chughtai B, et al : Real World Performance of Sacral Neuromodulation and OnabotulinumtoxinA for Overactive Bladder : Focus on Safety and Cost. J Urol 203 : 179-184, 2020

25） Leong RK, et al : Cost-Effectiveness Analysis of Sacral Neuromodulation and Botulinum Toxin A Treatment for Patients With Idiopathic Overactive Bladder. BJU Int 108 : 558-564, 2011